| 1 |
34602402 | Study of the radiosensitization of docetaxel in human esophageal squamous carcinoma ECA109 cell line. | 2021 May |
2 |
| 2 |
30248372 | Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression. | 2019 Mar 1 |
2 |
| 3 |
29997096 | [Infiltrating mast cells promote neuroendocrine differentiation and increase docetaxel resistance of prostate cancer cells by up-regulating p21]. | 2018 Jun 20 |
2 |
| 4 |
27593857 | Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro. | 2016 Nov |
1 |
| 5 |
21351099 | Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer. | 2012 Jan 15 |
1 |
| 6 |
22294184 | The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis. | 2012 Feb 14 |
1 |
| 7 |
23056370 | Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region. | 2012 |
1 |
| 8 |
21656826 | Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling. | 2011 Aug 1 |
5 |
| 9 |
18615564 | Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells. | 2008 Nov |
2 |
| 10 |
17458894 | Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics. | 2007 Sep |
4 |
| 11 |
15897421 | An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma. | 2005 May |
1 |